Eduovisual
Nervous System & Special Senses
Brain abscess: diagnosis and management
— Contiguous (~25–50%): otitis media/mastoiditis → temporal lobe or cerebellum; sinusitis (frontal/ethmoid) → frontal lobe; dental infection → frontal lobe.
— Hematogenous (~25%): endocarditis, lung abscess, bronchiectasis, right-to-left shunts; classically multiple abscesses at gray-white junction.
— Direct inoculation: penetrating trauma, neurosurgery.
— Cryptogenic (~20–30%): no source identified.
— Subacute headache (most common symptom, ~70%) progressing over days to weeks, often unilateral, worse than baseline.
— Headache + focal neuro deficit + fever = classic triad, but present in <50%.
— New seizure, especially focal, with systemic infection risk factor.
— Altered mental status in patient with known endocarditis, sinusitis, or recent dental work.
— Immunocompromised host (HIV CD4 <100, transplant, chemotherapy) with new neurologic symptoms.
Board pearl: Fever is absent in up to half of brain abscess patients at presentation — do not exclude the diagnosis because the patient is afebrile. The leading symptom is headache that is new, progressive, and poorly responsive to analgesics, often with subtle focal findings on careful exam.
— Headache: 70%; often hemicranial on the side of the abscess; worse with valsalva, recumbency, AM.
— Fever: 45–50% only.
— Focal neuro deficit: 30–50% (hemiparesis, aphasia, visual field cut, ataxia).
— Seizure: 25–35%, often focal with secondary generalization; frontal lobe lesions especially epileptogenic.
— Nausea/vomiting, papilledema, AMS: signs of raised ICP.
— Nuchal rigidity: suggests ventricular rupture or coexisting meningitis.
— ENT: recent or chronic otitis media, mastoiditis, sinusitis, dental abscess or extraction.
— Cardiac: known endocarditis, prosthetic valve, IV drug use, congenital heart disease (especially right-to-left shunt, tetralogy of Fallot).
— Pulmonary: bronchiectasis, lung abscess, empyema, hereditary hemorrhagic telangiectasia with pulmonary AVM.
— Neurosurgical/trauma: recent craniotomy, penetrating head injury, CSF leak, ventricular shunt.
— Immune status: HIV/CD4 count, transplant, steroids, biologics, neutropenia, uncontrolled diabetes.
— Travel/exposures: TB exposure, undercooked pork (neurocysticercosis mimic), Latin America/Asia residence.
Key distinction: Brain abscess vs bacterial meningitis — meningitis is hyperacute (hours) with prominent fever, meningismus, and diffuse symptoms; abscess is subacute with focal deficits and headache often disproportionate to systemic illness. LP is contraindicated in suspected abscess due to herniation risk.
— Cyanotic CHD + new headache → hematogenous abscess until proven otherwise.
— Poorly controlled diabetes + facial pain/black eschar → rhinocerebral mucormycosis (a fungal "abscess" with vascular invasion).
— HIV CD4 <100 + ring lesion → toxoplasmosis vs primary CNS lymphoma vs bacterial abscess.
Board pearl: A patient with chronic otitis media presenting with new headache and ataxia has a cerebellar abscess until imaging proves otherwise.
— Vitals: fever variable; Cushing reflex (hypertension, bradycardia, irregular respirations) signals impending herniation — emergency.
— Skin: stigmata of endocarditis (Janeway lesions, Osler nodes, splinters), IVDU track marks, telangiectasias of HHT.
— HEENT: tender mastoid, purulent otorrhea, sinus tenderness, dental caries/abscess, periorbital swelling (Pott puffy tumor = frontal osteomyelitis + subperiosteal abscess, often with underlying brain abscess).
— Cardiac: new murmur (endocarditis), clubbing (chronic pulmonary suppuration, cyanotic CHD).
— Frontal lobe abscess: personality change, executive dysfunction, contralateral leg weakness, expressive aphasia (dominant), urinary incontinence.
— Temporal lobe: receptive aphasia (dominant), contralateral homonymous superior quadrantanopia ("pie in the sky"), complex partial seizures.
— Parietal: contralateral sensory loss, neglect (non-dominant), Gerstmann syndrome (dominant).
— Cerebellar: ipsilateral ataxia, dysmetria, nystagmus, intention tremor; risk of obstructive hydrocephalus via 4th ventricle compression.
— Brainstem: cranial nerve palsies, crossed signs, gaze abnormalities.
— Papilledema (often absent in acute presentations — fundoscopy is sensitive only after days).
— CN VI palsy (false localizing sign).
— Decreased level of consciousness, posturing (decorticate/decerebrate).
Step 3 management: A patient with GCS ≤8, anisocoria, or Cushing triad needs immediate airway protection, head-of-bed elevation to 30°, hyperventilation to PaCO2 30–35 transiently, mannitol 1 g/kg or 3% hypertonic saline, and emergent neurosurgical consult — do not wait for MRI confirmation.
CCS pearl: Order serial neuro checks every 1–2 hours in admitted patients with suspected or confirmed abscess; sudden GCS drop suggests ventricular rupture (intraventricular pus) — mortality 27–85%, requires emergent EVD and intrathecal/IV antibiotics.
— Ring-enhancing lesion with smooth, thin wall; central T2 hyperintensity (pus), surrounding vasogenic edema.
— Diffusion-weighted imaging (DWI): restricted diffusion in the cavity — this is the single most specific finding distinguishing abscess from tumor (necrotic tumor usually does not restrict).
— ADC map: low signal (confirms true restriction).
— MR spectroscopy (when available): amino acids, lactate, acetate peaks; absence of choline.
— CBC (leukocytosis ~60–70%, often modest), CMP, glucose, coagulation panel.
— Blood cultures ×2 sets before antibiotics — positive in ~25% but critical when positive.
— ESR/CRP elevated but nonspecific; CRP useful for trending therapy response.
— HIV test, HbA1c, consider TB screen.
— Echocardiogram (TTE then TEE if endocarditis suspected) — mandatory if hematogenous source.
— Dental panoramic radiograph and sinus/temporal bone CT if contiguous source suspected.
— Risk of cerebral herniation due to mass effect.
— Yield low; CSF usually shows nonspecific changes unless ventricular rupture.
Board pearl: DWI restriction within a ring-enhancing lesion = abscess, not tumor. This is the most tested neuroradiology pearl for this topic. Glioblastoma and metastases have thicker, irregular walls and do not typically restrict centrally.
Step 3 management: Sequence on the CCS: (1) STAT non-contrast CT head to rule out herniation/hydrocephalus, (2) blood cultures ×2, (3) MRI brain with and without contrast, (4) start empiric antibiotics, (5) neurosurgery consult for aspiration. HIV test and echo should be in your order set.
— Indicated for lesions >2.5 cm, lesions causing significant mass effect, lesions failing medical therapy, or when microbiologic diagnosis is needed (almost always).
— Send aspirate for: Gram stain, aerobic and anaerobic culture, fungal culture, AFB smear/culture, 16S rRNA PCR if available, cytology.
— In immunocompromised: add Toxoplasma PCR, Nocardia stain, cryptococcal antigen, Aspergillus galactomannan.
— Otogenic/sinogenic/odontogenic: Streptococcus (especially S. anginosus/milleri group), anaerobes (Bacteroides, Prevotella, Fusobacterium), often polymicrobial.
— Post-neurosurgical/trauma: Staphylococcus aureus (including MRSA), Staphylococcus epidermidis, gram-negatives (Pseudomonas, Enterobacterales).
— Hematogenous from endocarditis: S. aureus, viridans strep.
— Hematogenous from lung: Strep, anaerobes, Nocardia, Actinomyces.
— HIV/AIDS (CD4 <100): Toxoplasma gondii (most common), Nocardia, Mycobacterium, Cryptococcus.
— Transplant/neutropenic: Aspergillus, Nocardia, Mucorales, Candida.
— Latin America/Asia: Taenia solium (neurocysticercosis), Mycobacterium tuberculosis.
— Toxoplasma IgG (negative IgG makes toxo unlikely in HIV).
— Cysticercosis serology.
— HIV viral load and CD4 count.
— Beta-D-glucan, galactomannan in immunocompromised.
Key distinction: In an HIV patient with CD4 <100 and ring-enhancing lesion(s) — toxoplasmosis typically shows multiple lesions at basal ganglia/gray-white junction with eccentric target sign, while primary CNS lymphoma shows fewer, periventricular lesions with subependymal spread and is thallium-201 SPECT or PET avid (toxo is not). Empirical anti-toxo trial for 2 weeks; if no response, brain biopsy.
CCS pearl: Always coordinate aspiration after blood cultures but before prolonged antibiotic exposure — even 48–72 hours of antibiotics can sterilize the cavity and prevent microbiologic diagnosis. If the patient is stable, neurosurgery aspiration within 24 hours is ideal.
— Unstable (herniation signs, GCS ≤8, hydrocephalus): ICU + emergent neurosurgery (EVD, decompression, aspiration) + empiric antibiotics simultaneously.
— Stable with abscess >2.5 cm or significant mass effect: Admit, neurosurgery for stereotactic aspiration within 24h, empiric antibiotics.
— Stable with abscess ≤2.5 cm, no mass effect, organism identified elsewhere (e.g., positive blood cultures with known endocarditis), or surgically inaccessible (deep, eloquent cortex, brainstem): Medical therapy alone may be considered with serial MRI every 1–2 weeks.
— Cerebritis stage (no capsule yet): Antibiotics first; aspiration deferred unless deteriorating.
— Size >2.5 cm, mass effect/midline shift, ventricular proximity (rupture risk), posterior fossa location, gas in cavity, failed medical therapy at 1–2 weeks, no microbiologic diagnosis.
— Multiple small abscesses, deep/eloquent location, cerebritis stage, surgical contraindication (severe coagulopathy), known causative organism from another sterile site.
— Use only when significant edema with mass effect threatens herniation or neurologic deterioration.
— Dexamethasone 4 mg IV q6h, taper as edema resolves.
— Drawback: Steroids reduce antibiotic penetration, decrease contrast enhancement (complicating imaging follow-up), and may worsen outcomes if used routinely.
— Start in all patients with seizure at presentation; many experts give prophylaxis for supratentorial lesions for up to 1–2 years given high seizure risk (~30–50% long-term).
— Levetiracetam preferred (no enzyme induction, fewer drug interactions).
Step 3 management: The exam expects you to (1) get the MRI, (2) get blood cultures, (3) start empiric antibiotics promptly, (4) consult neurosurgery for aspiration, (5) hunt and control the source (sinus drainage, dental extraction, mastoidectomy, valve surgery for endocarditis). Source control is essential for cure.
Board pearl: Medical therapy alone has higher failure rates; combined surgical aspiration + antibiotics is standard for most abscesses >2.5 cm.
— Choose agents with good CNS penetration and broad coverage based on source.
— Use IV bactericidal agents at maximum approved doses.
— Duration typically 6–8 weeks IV, sometimes followed by oral step-down for 2–3 months total in selected cases.
— Otogenic, sinogenic, odontogenic (or unknown community-acquired):
— Ceftriaxone 2 g IV q12h + Metronidazole 500 mg IV q8h.
— Add vancomycin (15–20 mg/kg q8–12h, trough 15–20) if MRSA risk or severe illness.
— Post-neurosurgical or post-traumatic:
— Vancomycin + Cefepime 2 g IV q8h (covers Pseudomonas and gram-negatives) + Metronidazole if penetrating trauma with soil contamination.
— Substitute meropenem 2 g IV q8h for cefepime if ESBL risk.
— Hematogenous from endocarditis:
— Vancomycin + Ceftriaxone; tailor to valve culture/blood culture sensitivities.
— Immunocompromised (HIV, transplant):
— Standard empiric + add TMP-SMX (for Nocardia and toxo) and consider voriconazole (Aspergillus) until pathogen identified.
— Empiric pyrimethamine + sulfadiazine + leucovorin for suspected toxoplasmosis (HIV, CD4 <100, positive toxo IgG, classic imaging).
— Streptococcus: Penicillin G 4 MU IV q4h or ceftriaxone.
— MSSA: Nafcillin 2 g IV q4h or cefazolin.
— MRSA: Vancomycin; linezolid alternative.
— Bacteroides/anaerobes: Metronidazole.
— Pseudomonas: Cefepime, meropenem, or ceftazidime.
— Nocardia: TMP-SMX ± imipenem or amikacin; prolonged 6–12 month course.
— Listeria: Ampicillin + gentamicin (synergy).
— Aspergillus: Voriconazole.
— Mucorales: Liposomal amphotericin B + surgical debridement.
Board pearl: Metronidazole and ceftriaxone are workhorses for community-acquired brain abscess because of excellent CNS penetration and anaerobic + streptococcal coverage. Do not forget metronidazole — anaerobes are often missed because they grow slowly in culture.
CCS pearl: Document renal function, allergies, and a vancomycin trough plan; order pharmacy consult for therapeutic drug monitoring.
— Preferred first-line procedure for most accessible abscesses >2.5 cm.
— Minimally invasive, allows microbiologic diagnosis, decompresses mass effect.
— May be repeated if recollection occurs.
— Procedural risks: hemorrhage (~1–4%), seeding, infection along tract, transient neuro deficit.
— Reserved for: multiloculated abscesses, posterior fossa lesions with brainstem compression, fungal abscesses (poorly responsive to antibiotics, need debridement), foreign body, traumatic abscess with bone fragments, failure of repeated aspirations.
— Higher morbidity but definitive in selected cases.
— Indicated for hydrocephalus (especially cerebellar abscess compressing 4th ventricle) or intraventricular rupture (allows ICP control and intraventricular antibiotic instillation).
— Sinus disease: ENT for functional endoscopic sinus surgery (FESS).
— Mastoiditis/chronic otitis: Mastoidectomy.
— Dental abscess: Dental extraction, root canal, oral surgery.
— Endocarditis with persistent vegetation or large vegetation (>10 mm) and embolic abscess: CT surgery consult for valve replacement.
— Pulmonary AVM (HHT): Interventional radiology for embolization to prevent recurrence.
— Congenital heart disease with R-to-L shunt: Definitive cardiac repair.
— Avoid LP and lumbar drains (herniation risk).
— Coordinate neurosurgery with ID and the source-control team early.
Step 3 management: A patient with otogenic temporal lobe abscess requires both stereotactic aspiration of the abscess and mastoidectomy — failure to address the source leads to recurrence. Coordinate ENT and neurosurgery on the same admission.
Board pearl: Cerebellar abscess from chronic otitis media is a neurosurgical emergency — small posterior fossa volume means rapid hydrocephalus and brainstem compression. Threshold for EVD and surgical drainage is low.
CCS pearl: After aspiration, order post-procedure MRI within 24–48 hours to document cavity size, then serial MRI every 1–2 weeks to confirm response to therapy.
— Presentation often atypical: AMS or new cognitive decline may dominate rather than headache or fever. Maintain low threshold for imaging.
— Higher baseline comorbidities (diabetes, CKD, malignancy) increase risk and complicate antibiotic dosing.
— Polypharmacy: check for drug interactions, especially with levetiracetam, vancomycin, and metronidazole.
— Surgical risk-stratify with cardiology and anesthesia; frailty assessment is appropriate before craniotomy.
— Goals-of-care conversation early — recovery from severe abscess in frail elderly may be limited.
— Vancomycin: Dose by weight, target AUC 400–600 (or trough 15–20); reduce frequency in CKD; daily levels in AKI/dialysis.
— Cefepime: Renally adjust; cefepime neurotoxicity (encephalopathy, myoclonus, non-convulsive status) is more common in elderly with renal impairment and at high doses — monitor mental status.
— Meropenem: Renally adjust; lower seizure threshold than imipenem but still possible.
— Piperacillin-tazobactam: Not preferred (poor CNS penetration).
— TMP-SMX: Hyperkalemia, AKI risk; reduce dose with CrCl <30.
— Aminoglycosides: Avoid if possible; poor CNS penetration and nephrotoxic.
— Metronidazole: Reduce dose in severe hepatic dysfunction (Child-Pugh C) to avoid neurotoxicity (peripheral neuropathy, encephalopathy).
— Ceftriaxone: Caution in biliary disease — biliary sludging; avoid in neonates with hyperbilirubinemia.
— Voriconazole: Hepatotoxic; monitor LFTs, dose-reduce in Child-Pugh A/B, avoid in Child-Pugh C.
— Linezolid: Lactic acidosis, thrombocytopenia (monitor weekly CBC after 2 weeks).
Board pearl: Cefepime-induced neurotoxicity is a classic Step 3 stem — a renally impaired elderly patient on cefepime develops new myoclonus, confusion, or NCSE; EEG shows generalized periodic discharges. Treatment: stop cefepime, consider hemodialysis if severe.
Step 3 management: Order pharmacy-driven renal dose adjustment, daily renal function panels, vancomycin troughs, and weekly LFTs/CBC during prolonged antibiotic courses. Anticipate and counsel about C. difficile risk during 6–8 weeks of broad-spectrum therapy.
— Rare but high-stakes. MRI without gadolinium is preferred in pregnancy; gadolinium is category C — use only if benefit clearly outweighs risk (severe abscess where MRI is essential to plan surgery).
— CT with contrast is acceptable with abdominal shielding when MRI unavailable.
— Safe antibiotics: ceftriaxone, metronidazole (avoid in 1st trimester if possible, though benefit usually outweighs risk), vancomycin — all category B/considered safe.
— Avoid: TMP-SMX in 1st trimester (neural tube defects) and near term (kernicterus); fluoroquinolones; tetracyclines; aminoglycosides (ototoxicity).
— Multidisciplinary: OB, neurosurgery, ID, neonatology if near term.
— Most common sources: otitis/mastoiditis, sinusitis, cyanotic congenital heart disease (especially tetralogy of Fallot), neonatal meningitis (Citrobacter, Cronobacter cause necrotizing abscesses).
— Presentation: irritability, vomiting, bulging fontanelle in infants; behavior change, headache, seizure in older children.
— Empiric: ceftriaxone + metronidazole + vancomycin; adjust for neonates (cefotaxime + ampicillin + metronidazole or meropenem).
— Definitive cardiac repair of cyanotic CHD prevents recurrence.
— CD4 <100: Toxoplasmosis is the most common cause; empiric sulfadiazine + pyrimethamine + leucovorin for 6 weeks induction, then secondary prophylaxis until CD4 >200 for 6 months on ART.
— If no clinical/radiographic response in 2 weeks → brain biopsy to rule out primary CNS lymphoma (EBV-driven, treat with high-dose methotrexate + ART).
— Start or optimize ART; watch for IRIS.
— Think Aspergillus, Nocardia, Mucorales, Toxoplasma reactivation (especially in cardiac transplant from seropositive donor to seronegative recipient).
— Voriconazole for Aspergillus; liposomal amphotericin B + surgical debridement for Mucor.
Key distinction: Toxoplasmosis vs primary CNS lymphoma in HIV — toxo has multiple lesions, eccentric target sign, responds to empiric therapy in 2 weeks; lymphoma has fewer lesions, periventricular, thallium/PET avid, EBV PCR positive in CSF.
Board pearl: A child with tetralogy of Fallot and new headache/seizure has a brain abscess until proven otherwise — right-to-left shunt bypasses the pulmonary filter.
— Cerebral herniation from mass effect and edema — leading cause of early mortality.
— Intraventricular rupture — sudden deterioration, mortality 27–85%; requires emergent EVD and intraventricular antibiotics (vancomycin and/or gentamicin).
— Hydrocephalus — especially with cerebellar or periventricular abscesses; treat with EVD then possible VP shunt after infection cleared.
— Seizures — acute and long-term; lifetime risk ~30–50% after supratentorial abscess.
— Stroke — septic embolism, vasculitis, or mycotic aneurysm rupture (especially with endocarditis).
— Cerebral edema — vasogenic; selective dexamethasone use.
— Recurrence/treatment failure — usually due to inadequate source control, premature antibiotic discontinuation, or resistant organism. Repeat MRI and aspiration.
— Multilocular abscess development.
— Subdural empyema or epidural abscess as adjacent collections.
— Antibiotic toxicities: vancomycin nephrotoxicity, cefepime neurotoxicity, metronidazole peripheral neuropathy (especially with prolonged courses), C. difficile colitis, linezolid cytopenias.
— Catheter-related complications: PICC-line DVT, bloodstream infection — common during 6–8 weeks of IV therapy.
— Persistent neurologic deficit (~20–30%): hemiparesis, aphasia, cognitive impairment, visual field defects.
— Epilepsy requiring chronic AED therapy.
— Cognitive/behavioral changes, especially after frontal lobe abscess.
— Mortality: overall ~10–20% in modern series, higher in immunocompromised, ventricular rupture, comatose presentation, and fungal etiology.
Step 3 management: A patient on day 5 of treatment with sudden GCS drop and headache → STAT CT to evaluate for ventricular rupture, rebleed, or worsening edema → neurosurgery for EVD if hydrocephalus or rupture; intensify antibiotics; consider intraventricular instillation.
CCS pearl: During the 6–8 week IV antibiotic course, schedule weekly CBC, CMP, drug levels (vancomycin), and biweekly imaging (MRI to track cavity size). C. diff testing on any new diarrhea.
Board pearl: Mycotic aneurysm rupture is a late, catastrophic complication of endocarditis-associated abscess — screen with CTA/MRA if aneurysm suspected and treat with endovascular coiling or clipping.
— GCS ≤12 or any acute decline in mental status.
— Signs of raised ICP, herniation, or imaging with significant midline shift (>5 mm).
— Status epilepticus or recurrent seizures.
— Hemodynamic instability or sepsis (concomitant endocarditis, bacteremia).
— Post-craniotomy or post-EVD for first 24–48h.
— Intraventricular rupture.
— Neurosurgery — for aspiration/drainage decisions, EVD, ICP monitoring.
— Infectious diseases — to guide empiric and definitive antibiotic regimen, duration, and source workup.
— Neurology — seizure management, EEG if AMS without obvious cause (rule out NCSE).
— Source-specialty consult: ENT (otogenic/sinogenic), oral maxillofacial surgery (dental), cardiology + cardiothoracic surgery (endocarditis), pulmonology + IR (lung abscess/AVM).
— Cardiology with TEE for any cryptogenic or hematogenous abscess to rule out endocarditis.
— Ophthalmology for fundoscopy and visual field documentation.
— PT/OT/Speech early for rehabilitation planning.
— Pharmacy for vancomycin dosing and renal adjustments.
— Palliative care/ethics if prognosis poor or decisional capacity in question.
— Stable patient, post-aspiration, on antibiotics, no ICP concerns → step-down or floor with q4h neuro checks.
— Frequent neuro checks (q1–2h) needed for the first 24–48h after any procedure.
Step 3 management: On the CCS case, after the initial stabilization and MRI, your order list should include: neurosurgery consult, ID consult, source-specialty consult, blood cultures ×2, empiric antibiotics, antiepileptic, HOB 30°, neuro checks q2h, MRI brain follow-up, echocardiogram, HIV test, HbA1c. Forgetting source control or echo are classic dings.
Board pearl: A patient with brain abscess and known IV drug use → always order TTE, then TEE if TTE non-diagnostic — endocarditis until proven otherwise.
CCS pearl: Update the family at admission and after each major change; document goals of care. Transition to floor when neurologically stable, source controlled, on tailored antibiotics, and pain managed.
— Hyperacute (hours), prominent fever, meningismus, photophobia, diffuse rather than focal symptoms.
— LP shows neutrophilic pleocytosis, low glucose, high protein.
— LP is the diagnostic test (safe if no focal deficit or papilledema); empiric ceftriaxone + vancomycin ± ampicillin (elderly/immunocompromised) + dexamethasone.
— Distinguishing feature: meningitis lacks focal mass on imaging.
— Subacute fever, AMS, seizures, temporal lobe edema on MRI (T2/FLAIR hyperintensity, no ring enhancement).
— CSF: lymphocytic pleocytosis, normal glucose, elevated protein, HSV PCR positive.
— Empiric IV acyclovir while awaiting PCR — do not delay; treatment improves mortality.
— Crescent-shaped extra-axial collection, often from sinusitis or otitis.
— Rapid progression, high fever, seizures common.
— Surgical emergency — craniotomy + antibiotics.
— Lens-shaped collection, often from sinusitis or post-op.
— Slower progression than subdural empyema; Pott puffy tumor (frontal bone osteomyelitis with subperiosteal abscess) classically associated.
— Cavernous: chemosis, proptosis, CN III/IV/V1/VI palsies, often from facial/sinus infection.
— Sagittal: headache, seizures, bilateral motor signs, parasagittal edema.
— Diagnose with MRV/CTV; treat with antibiotics + anticoagulation (controversial but generally recommended for septic sinus thrombosis without hemorrhage).
— Subacute headache, low-grade fever, cranial nerve palsies, basal meningeal enhancement, tuberculomas (ring lesions).
— CSF: lymphocytic, very high protein, low glucose, AFB smear/PCR/culture.
— Treat: RIPE + dexamethasone for 9–12 months.
— Endemic exposure, multiple cystic lesions in various stages, scolex visible.
— Treat: albendazole + praziquantel + steroids + antiepileptics; avoid antiparasitics in untreated calcified lesions — risk of inflammatory worsening.
Key distinction: Ring enhancement + DWI restriction = pyogenic abscess; ring enhancement without DWI restriction = tumor (GBM, metastasis) or radiation necrosis.
Board pearl: Empiric IV acyclovir should be added when HSV encephalitis is in the differential — delay worsens outcomes; stopping later if PCR negative is low risk.
— Glioblastoma multiforme: Older adult, ring-enhancing with thick irregular wall, central necrosis, no DWI restriction, crosses corpus callosum ("butterfly glioma"), elevated choline on MRS.
— Lower-grade gliomas: Less enhancement, more infiltrative.
— Workup: MRI with perfusion, MRS, biopsy.
— Multiple lesions at gray-white junction (mimics multiple hematogenous abscesses), ring enhancement common.
— History of primary cancer (lung, breast, melanoma, colorectal, renal); systemic staging.
— No DWI restriction in necrotic center; surrounding edema often disproportionate.
— Immunocompromised (HIV, transplant) or immunocompetent elderly.
— Periventricular, homogeneously enhancing, hyperdense on non-contrast CT, thallium/PET avid, EBV PCR positive in CSF (HIV-associated).
— Treat with high-dose methotrexate-based regimen.
— Incomplete ring enhancement ("open ring sign" pointing toward gray matter), often younger patient, other characteristic lesions.
— CSF oligoclonal bands; treat with steroids.
— History of CNS radiation (months to years prior).
— Ring-enhancing lesion at prior radiation field; PET/MR perfusion differentiates from tumor recurrence.
— Vascular distribution, hyperacute onset, no fever.
— DWI restriction in arterial territory, not ring-shaped.
— Multiple infarcts, enhancement of vessel walls, CSF inflammation; angiography shows beading.
— Endocarditis can produce multiple small DWI-bright lesions without ring enhancement; treat the endocarditis.
Key distinction: Open-ring sign = tumefactive demyelination (treat with steroids, not antibiotics); closed ring with DWI restriction = abscess; closed ring, thick irregular, no DWI restriction = tumor.
Board pearl: When in doubt, stereotactic biopsy/aspiration is the definitive test. Empiric antibiotics for 1–2 weeks with serial MRI is reasonable when abscess is highly probable and biopsy is contraindicated — failure to shrink → biopsy.
Step 3 management: A patient with known metastatic lung cancer and new ring-enhancing lesion → MRI with DWI and perfusion; if abscess unlikely and lesion likely metastatic, refer to neuro-oncology for steroids, SRS/WBRT, and systemic therapy planning rather than antibiotics.
— Neurologically stable, seizures controlled, pain managed on oral regimen.
— Source control achieved (sinus drainage, dental work, valve surgery if needed).
— IV access secured for outpatient parenteral antibiotic therapy (OPAT) — typically PICC line.
— Pharmacy and OPAT team handoff documented.
— Follow-up appointments scheduled with ID, neurosurgery, neurology, and primary care.
— IV antibiotics 6–8 weeks is standard for bacterial abscess.
— Some advocate oral step-down for the final 2–4 weeks (or longer for total 3–6 months) using high-bioavailability agents (linezolid, fluoroquinolones, TMP-SMX, metronidazole) — emerging evidence (e.g., POET-like extrapolation) but not yet standard for brain abscess.
— Nocardia: 6–12 months; Toxo: 6 weeks induction + chronic maintenance until immune reconstitution; TB: 9–12 months; fungal: ≥6–12 months.
— Endocarditis: Dental prophylaxis with amoxicillin 2 g 30–60 min before dental procedures in patients with prosthetic valves, prior IE, congenital heart disease (per AHA).
— Cyanotic CHD or pulmonary AVM: Definitive surgical/embolization repair to eliminate right-to-left shunt.
— Chronic sinusitis: ENT follow-up, allergy management, FESS as indicated.
— Chronic otitis/cholesteatoma: Mastoidectomy and ENT follow-up.
— Dental hygiene: Regular dental care; treat caries and periodontal disease.
— IV drug use: Harm reduction, MAT (buprenorphine/methadone), hepatitis/HIV screening, naloxone.
— HIV: ART, OI prophylaxis (TMP-SMX for toxo if CD4 <100 and IgG positive).
— Continue AED for ≥1–2 years after supratentorial abscess; longer if seizures occurred.
— EEG and neurology guidance for tapering.
— Counsel re: driving restrictions (state-specific, typically seizure-free 6–12 months) — document this conversation.
Step 3 management: Discharge order set must include: OPAT antibiotics with pharmacy and home health coordination, AED, follow-up MRI in 2–4 weeks, ID clinic in 1 week, neurosurgery in 2–4 weeks, weekly labs (CBC, CMP, drug levels) faxed to ID, and driving/seizure precautions counseling.
Board pearl: Always close the loop on the source — recurrent abscess is the rule when underlying focus (dental, sinus, AVM, valve) is untreated.
— MRI with contrast and DWI at 2 weeks after starting therapy, then every 2–4 weeks until resolution.
— Cavity should shrink and enhancement diminish over weeks; residual enhancement may persist for months — do not equate persistent enhancement with treatment failure if clinically improving.
— Final MRI at 3–6 months to document resolution; baseline for future comparisons.
— Weekly: CBC with differential, CMP (renal/hepatic), CRP/ESR (trend).
— Vancomycin: trough or AUC monitoring 2× weekly initially, then weekly.
— Linezolid: weekly CBC after 2 weeks (cytopenias).
— TMP-SMX: K+, creatinine, CBC.
— Metronidazole >4–6 weeks: monitor for peripheral neuropathy clinically.
— PICC line: signs of infection, DVT (arm swelling, pain) — counsel patient on red flags.
— Neurology at 1 month, then every 3 months for AED titration and seizure monitoring.
— EEG before AED taper consideration.
— Repeat neuropsychological assessment if cognitive deficits.
— Early PT/OT consult during admission; transition to inpatient rehab if functional impairment.
— Speech therapy for aphasia, dysphagia.
— Vocational rehab for return-to-work planning.
— Driving evaluation — must meet state seizure-free interval; physician reporting laws vary.
— Recurrence symptoms: new headache, fever, focal deficit, seizure → immediate ED.
— Source-control adherence (dental hygiene, ART, sinus care).
— Endocarditis prophylaxis if applicable.
— Mental health screening — depression/PTSD after ICU stay is common.
— Family/caregiver support and education.
Step 3 management: Outpatient cadence — ID clinic at week 1, then biweekly during OPAT; neurosurgery at 4 weeks with MRI; PCP within 2 weeks for medication reconciliation and overall wellness; neurology at 1 month; specialty source clinic (ENT, dental, cardiology) per source.
Board pearl: Persistent rim enhancement on MRI months after treatment is expected if the patient is asymptomatic and cavity is shrinking — do not extend antibiotics based on imaging alone if clinical and inflammatory markers have normalized.
CCS pearl: Always document return precautions in discharge summary and counsel both patient and caregiver — early recognition of recurrence preserves outcomes.
— Stereotactic aspiration and craniotomy require detailed consent: risks of hemorrhage, infection, neurologic deficit, seizure, death.
— In altered patients without capacity, obtain consent from surrogate decision-maker per state hierarchy (spouse, adult child, parent, sibling) and document urgency.
— Two-physician emergency consent doctrine applies when life- or limb-threatening emergency precludes surrogate contact.
— Patients with frontal lobe abscesses may have preserved language but impaired executive function — they can appear conversational yet lack capacity. Formal assessment is essential before consenting to procedures or AMA discharge.
— Seizures and driving: physician reporting laws vary by state (CA, NJ, OR, PA require reporting; most states encourage but do not mandate). Document the counseling regardless.
— HIV: All states require reporting of new HIV diagnoses to public health.
— Endocarditis from IV drug use: Not directly reportable, but trigger for harm-reduction referral and partner notification for HIV/HCV.
— Suspected child or elder abuse if relevant (e.g., poor dental hygiene with neglect).
— OPAT handoff is a high-risk transition. Confirm: PICC line care plan, antibiotic infusion schedule, lab draw schedule and result routing back to ID, emergency contact info.
— Medication reconciliation at discharge: AEDs, antibiotics, analgesics, prophylactic agents — verify with patient and caregiver.
— Use teach-back to confirm understanding of red-flag symptoms.
— In severe abscess with poor prognosis (comatose, multilobar, severe comorbidity), initiate early palliative care consultation.
— Document code status, healthcare proxy, advance directives.
— VTE prophylaxis: pharmacologic prophylaxis is generally safe 24–48 hours after neurosurgical intervention with stable imaging; SCDs in interim.
— Fall risk, delirium prevention, C. difficile precautions during prolonged antibiotic exposure.
— Antibiotic stewardship: narrow once cultures available; coordinate with ID.
Step 3 management: When transferring a patient from acute hospital to a SNF or rehab on OPAT, perform a structured handoff (verbal + written): active issues, medications, lines, follow-up appointments, code status, contingency plans. This is the single highest-yield patient-safety item in this disease's longitudinal arc.
Board pearl: Document driving counseling for any patient with a brain abscess and seizure — both for safety and for medicolegal protection.
— Otitis/mastoiditis → temporal lobe or cerebellum.
— Frontal/ethmoid sinusitis → frontal lobe.
— Sphenoid sinusitis → temporal lobe or cavernous sinus.
— Dental → frontal lobe.
— Hematogenous → multiple, MCA territory, gray-white junction.
— Otogenic/sinogenic → Strep anginosus + anaerobes (polymicrobial).
— Post-neurosurgical → S. aureus, gram-negatives.
— Endocarditis → S. aureus, viridans strep.
— HIV CD4 <100 → Toxoplasma.
— Neutropenic/transplant → Aspergillus, Mucor, Nocardia.
— Cyanotic CHD → Strep, anaerobes (hematogenous).
— DWI restriction in cavity = abscess.
— Open ring sign = tumefactive demyelination.
— Eccentric target sign = toxoplasmosis.
— Subependymal spread + periventricular = CNS lymphoma.
— Crescent extra-axial = subdural empyema.
— Lens-shaped extra-axial = epidural abscess.
— Pott puffy tumor = frontal osteomyelitis + subperiosteal abscess.
— Ceftriaxone + metronidazole ± vancomycin = empiric community-acquired.
— Vancomycin + cefepime + metronidazole = post-neurosurgical/traumatic.
— Cefepime → encephalopathy in renal impairment.
— Metronidazole → peripheral neuropathy, disulfiram reaction with alcohol.
— Linezolid → cytopenias, serotonin syndrome with SSRIs, MAOI activity.
— TMP-SMX → hyperkalemia, AKI, SJS.
— Voriconazole → visual disturbance, hepatotoxicity, QT prolongation.
— Lemierre syndrome: Fusobacterium pharyngitis → septic IJ thrombophlebitis → septic pulmonary emboli → can seed brain.
— Citrobacter koseri in neonates → necrotizing brain abscess.
— Tetralogy of Fallot + new headache → brain abscess.
— HHT + brain abscess → pulmonary AVM until proven otherwise (screen with contrast echo).
— Diabetes + facial pain/black eschar → mucormycosis.
— Mortality ~10–20% modern series; ~30–50% with ventricular rupture.
— Sequelae (epilepsy, focal deficit) in 20–30%.
Board pearl: Pott puffy tumor in an adolescent with frontal headache → image the brain — frontal lobe abscess is found in a substantial minority and changes management urgency.
Step 3 management: When you see HHT + neurologic symptoms in a stem, order contrast echocardiogram (bubble study) to screen for pulmonary AVM as the route for paradoxical embolization.
— 40-year-old with chronic otitis media presents with 2 weeks of worsening right-sided headache and new ataxia. T 38.2. MRI: ring-enhancing lesion in right cerebellum with DWI restriction.
— Answer path: Empiric ceftriaxone + metronidazole + vancomycin → neurosurgery for aspiration → ENT for mastoidectomy → 6–8 weeks IV antibiotics.
— 35-year-old HIV with CD4 45 presents with new focal seizure. MRI: multiple ring-enhancing lesions in basal ganglia with eccentric target sign. Toxo IgG positive.
— Answer: Empiric sulfadiazine + pyrimethamine + leucovorin for 2 weeks; reimage. Response = continue 6 weeks + secondary prophylaxis + ART. No response → brain biopsy for lymphoma.
— 60-year-old 3 weeks after craniotomy with new fever, headache, wound erythema. MRI: ring-enhancing lesion at surgical site.
— Answer: Vancomycin + cefepime + metronidazole; neurosurgery for washout and aspiration; remove infected hardware.
— IV drug user with S. aureus bacteremia and new right hemiparesis. MRI: multiple small lesions at gray-white junction, one with ring enhancement and DWI restriction.
— Answer: Vancomycin + ceftriaxone; TEE for vegetation; cardiology + CT surgery; neurosurgery if large abscess; 6–8 weeks IV; addiction medicine referral.
— 8-year-old with tetralogy of Fallot, new seizure. CT: ring-enhancing parietal lesion.
— Answer: Ceftriaxone + metronidazole; neurosurgery aspiration; plan definitive cardiac repair to prevent recurrence.
— Adolescent with frontal forehead swelling and new behavior change after sinusitis. CT: frontal bone osteomyelitis with subperiosteal collection and underlying frontal lobe ring-enhancing lesion.
— Answer: IV antibiotics + ENT for sinus drainage + neurosurgery for abscess drainage.
— Elderly with CKD on cefepime for brain abscess develops myoclonus and confusion. EEG: generalized periodic discharges.
— Answer: Stop cefepime; switch to alternative (meropenem with renal adjustment or carbapenem-sparing if possible); consider hemodialysis.
— Patient discharged after brain abscess and one seizure. Asks if he can drive.
— Answer: Counsel no driving until seizure-free per state law (typically 6–12 months); document; consider physician reporting per state requirements.
Board pearl: When a ring-enhancing lesion shows DWI restriction → abscess; when it doesn't and the patient has a cancer history → metastasis; when there's an open ring sign in a young woman → demyelination.
Step 3 management: Always look in the stem for the source (otitis, sinus, dental, valve, shunt) — answering "treat the brain only" without source control is the wrong choice.
Brain abscess is a focal suppurative CNS infection that demands rapid contrast-enhanced MRI with DWI, blood cultures, empiric source-directed IV antibiotics, stereotactic aspiration for diagnosis and decompression of lesions >2.5 cm, and simultaneous source control — followed by 6–8 weeks of tailored IV therapy and longitudinal monitoring for seizures, recurrence, and neurologic recovery.
— Subacute headache + focal deficit ± fever (classic triad in <50%) in a patient with otitis, sinusitis, dental disease, endocarditis, cyanotic CHD, immunocompromise, or trauma.
— MRI with contrast and DWI is the test of choice — ring enhancement with central DWI restriction distinguishes abscess from tumor.
— Blood cultures ×2, echocardiogram, HIV test, source-hunting imaging (sinus CT, chest CT, dental); LP is contraindicated.
— Community-acquired/otogenic/sinogenic/dental: ceftriaxone + metronidazole ± vancomycin.
— Post-neurosurgical/trauma: vancomycin + cefepime + metronidazole.
— HIV CD4 <100 with multiple lesions: empiric sulfadiazine + pyrimethamine + leucovorin for toxoplasmosis; biopsy if no response in 2 weeks.
— Duration: 6–8 weeks IV (longer for Nocardia, fungal, TB).
— Always treat the source — mastoidectomy, FESS, dental extraction, valve surgery, AVM embolization, ART, definitive CHD repair.
— Continue AED (often 1–2 years), schedule serial MRI every 2–4 weeks, weekly OPAT labs, ID/neurosurgery/source-specialty follow-up.
— Counsel on seizure precautions, driving restrictions, recurrence red flags; arrange palliative care if prognosis poor.
Board pearl: The exam rewards the trio of early MRI, empiric antibiotics with anaerobic coverage, and source control — miss any one and the patient (and the question) goes wrong.
Step 3 management: Think longitudinally — admission CCS orders include neurosurgery + ID + source consult + echo + HIV; discharge orders include OPAT, AED, follow-up imaging, driving counseling, and structured handoff to outpatient ID.
CCS pearl: Brain abscess is a multi-team, multi-week disease — success depends on coordinated care across specialties and a meticulous transition to outpatient OPAT.